Pre-launch · We're opening Reserve Meds to a limited first cohort. Join the waitlist ›

Batten Disease

Neurology ยท Specialty and rare-disease access

About Batten Disease

A family of rare neurodegenerative disorders.

Access to specialty treatment

Patients with Batten Disease living in countries where their prescribed treatment is not registered or not reimbursed can explore Named Patient Program access. Reserve Meds coordinates this pathway: we work with your physician, help prepare destination-country documentation, and source the drug from DSCSA-compliant US wholesalers.

What to discuss with your physician

  • Whether a specific US-approved drug is clinically appropriate for your case.
  • Whether your treating physician can issue a prescription for NPP access.
  • What documentation your destination country requires for the specific drug.
  • Any dose, monitoring, or administration considerations.

Related drugs

Start a request

Request a drug for Batten Disease

Review & oversight. Content on this page is reviewed by Reserve Meds's clinical and regulatory team. A US-licensed pharmacist reviews every prescription before dispensing. Regulatory posture is informational, not legal advice; case-specific questions route to retained outside counsel. Review methodology ›
Last medically reviewed: .